Swirsky Douglas J Insider Trades

Insider Trading History

Track insider trading activity for Swirsky Douglas J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MaxCyte
MaxCyte MXCT
CHIEF FINANCIAL OFFICER
Holding Value $187k 151,669 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.32k 10,142 shares
$0.82
$1.23
MaxCyte
MaxCyte MXCT
CHIEF FINANCIAL OFFICER
Holding Value $199k 161,811 shares
Last Trade
Aug 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$64.5k 50,000 shares
$1.29
$1.23
MaxCyte
MaxCyte MXCT
CHIEF FINANCIAL OFFICER
Holding Value $138k 111,811 shares
Last Trade
Mar 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.1k 6,939 shares
$3.18
$1.23
MaxCyte
MaxCyte MXCT
CHIEF FINANCIAL OFFICER
Holding Value $185k 150,000 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$494k 150,000 shares
$3.29
$1.23
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $248k 90,000 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$785k 90,000 shares
$8.72
$2.75
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $248k 90,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.69M 90,000 shares
$96.60
$2.75
MaxCyte
MaxCyte MXCT
CHIEF FINANCIAL OFFICER
Holding Value $277k 225,000 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$970k 225,000 shares
$4.31
$1.23
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $198k 71,925 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.08M 37,500 shares
$55.50
$2.75
MaxCyte
MaxCyte MXCT
Chief Financial Officer
Holding Value $431k 350,000 shares
Last Trade
Mar 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.44M 350,000 shares
$4.11
$1.23
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $32.2k 11,700 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.44M 11,700 shares
$123.00
$2.75
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $68.8k 25,000 shares
Last Trade
Sep 14, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.8M 25,000 shares
$312.00
$2.75
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $322k 117,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.8M 117,000 shares
$357.00
$2.75
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $142k 60,000 shares
Last Trade
Sep 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87M 60,000 shares
$1,449.60
$2.36
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $220k 80,000 shares
Last Trade
Jun 24, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.7M 80,000 shares
$384.00
$2.75
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $26.8k 9,750 shares
Last Trade
Jun 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.29M 9,750 shares
$645.00
$2.75
Ocuphire Pharma
Ocuphire Pharma OCUP
President And CEO
Holding Value $58.5k 50,000 shares
Last Trade
Jan 29, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$387k 50,000 shares
$7.74
$1.17
Ocuphire Pharma
Ocuphire Pharma OCUP
President And CEO
Holding Value $585k 500,000 shares
Last Trade
Nov 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.54M 500,000 shares
$13.08
$1.17
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $53.6k 19,500 shares
Last Trade
Oct 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.3M 19,500 shares
$783.00
$2.75
Ocuphire Pharma
Ocuphire Pharma OCUP
President And CFO
Holding Value $293k 250,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.3M 250,000 shares
$25.20
$1.17
Cellectar Biosciences
Cellectar Biosciences CLRB
Director
Holding Value $27.5k 10,000 shares
Last Trade
May 31, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.2M 10,000 shares
$5,220.00
$2.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up